Evidence map›Paper›PMID 36652666›Full record

ArticleJCO precision oncology2023

Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.

Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen, Po-Hung Lin, Chiao-En Wu, Cheng-Keng Chuang, Chun-Nan Yeh

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO precision oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wen-Kuan HuangDivision of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.ORCID 0000-0001-7789-8347
Shih-Chiang HuangDepartment of Anatomic Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.ORCID 0000-0002-5092-4434
Chien-Ming ChenDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Taipei, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
Po-Hung LinDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.ORCID 0000-0001-8245-4302
Chiao-En WuDivision of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.ORCID 0000-0002-1081-8805
Cheng-Keng ChuangDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.ORCID 0000-0001-6154-1220
Chun-Nan YehDepartment of Surgery and GIST Team, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
Chang Gung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SarcomaCyclin-Dependent Kinase 4HumansProto-Oncogene Proteins c-mdm2PyrazolesPyrimidinesTropomyosinCDK4 protein, humanCyclin-Dependent Kinase 4larotrectinibMDM2 protein, humanProto-Oncogene Proteins c-mdm2PyrazolesPyrimidinesTPM3 protein, humanTropomyosin

Identifiers

PMID36652666
PMCPMC9928762
OpenAlexW4317379817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.